Can Vitamin B5 Help Reduce Scalp Dryness and Irritation Linked to Hair Loss?

Scalp dryness and irritation are common concerns among people experiencing hair thinning. Symptoms such as tightness, flaking, itching, and redness often accompany various forms of hair loss, including androgenetic alopecia and telogen effluvium. Vitamin B5, also known as pantothenic acid, is frequently marketed in shampoos and supplements as a soothing and hydrating ingredient. But does scientific research support the idea that vitamin B5 can reduce scalp dryness and irritation linked to hair loss?

To answer this question properly, we must examine clinical evidence, biological mechanisms, dermatological research, and real-world user experiences.

Understanding Vitamin B5 and Its Role in Skin Health

Vitamin B5, or pantothenic acid, is a water-soluble B-vitamin recognized by the National Institutes of Health (NIH) as an essential nutrient involved in energy metabolism and the synthesis of coenzyme A. Coenzyme A is necessary for fatty acid metabolism and the production of lipids that contribute to the skin barrier.

According to the NIH Office of Dietary Supplements, pantothenic acid deficiency is rare but can lead to dermatological symptoms such as skin irritation and numbness (NIH, 2022). The skin barrier is the outermost protective layer of the skin, composed largely of lipids. When this barrier is compromised, moisture escapes more easily, leading to dryness and irritation.

In cosmetic formulations, vitamin B5 is typically used in the form of panthenol, a provitamin that converts into pantothenic acid in the skin. The European Commission’s CosIng database, which regulates cosmetic ingredients in Europe, recognizes panthenol as a skin conditioning and hair conditioning agent (European Commission CosIng Database, 2023). This means its primary approved role is to improve moisture retention and surface smoothness.

Can Vitamin B5 Improve Scalp Dryness?

Scientific evidence suggests that panthenol has moisturizing properties. A 2002 review of topical dexpanthenol in skin disorders describes its use as a moisturiser and in skin barrier repair (Ebner et al., 2002). The studies it covers were on general skin, not specifically the scalp, and did not involve people with hair loss.

The scalp is biologically similar to other skin but contains more hair follicles and sebaceous glands, which produce oil. Therefore, while we can reasonably infer that panthenol may hydrate the scalp, direct clinical trials on scalp dryness specifically remain limited.

The U.S. Food and Drug Administration (FDA) does not classify vitamin B5 as a treatment for scalp disorders or hair loss. It is regulated as a cosmetic ingredient when used topically (FDA, 2023).

Does Vitamin B5 Reduce Irritation Linked to Hair Loss?

Scalp irritation in hair loss can result from inflammation, seborrheic dermatitis, contact dermatitis from hair products, or increased sensitivity during androgenetic alopecia. Inflammation means the immune system is activated in the skin, leading to redness, itching, and sometimes micro-damage around hair follicles.

No published trial has tested dexpanthenol on scalp irritation in people with hair loss. Its reported benefits on inflammation and barrier repair come from skin studies summarised in reviews such as Ebner et al. (2002), not from hair loss populations.

In summary, reviews describe panthenol as a skin moisturiser that can help barrier repair. Evidence linking it to less scalp irritation in people with hair loss is indirect.

Panthenol can itself irritate. It is an uncommon but recognised cause of allergic contact dermatitis, and a 2025 review reported that positive patch-test rates have risen to about 1.2% in recent testing (Weber & Hylwa, 2025). If a panthenol product makes the scalp itchier or redder, stop using it and ask a doctor.

Can Vitamin B5 Treat Hair Loss Itself?

There is no high-quality clinical evidence demonstrating that vitamin B5 alone treats androgenetic alopecia. The NIH and FDA do not list pantothenic acid as an approved therapy for hair loss. Hair loss in most healthy individuals is primarily driven by dihydrotestosterone (DHT), a hormone derived from testosterone that miniaturizes hair follicles over time.

According to large clinical trials published in PubMed, the treatments with the most trial evidence for male pattern hair loss are finasteride and minoxidil. Finasteride is a prescription medicine approved for hair loss in men only; women who are or may become pregnant must not take it or handle crushed or broken tablets. Finasteride reduces DHT levels, while minoxidil prolongs the growth phase of hair follicles.

No controlled human trial has shown that vitamin B5 changes DHT levels or the hair growth cycle. It is a scalp-care ingredient, not a hair loss treatment.

User experience

Within the Tressless community, discussions about vitamin B5 or panthenol often center around its inclusion in shampoos rather than as a standalone treatment. Community members report subjective improvements in scalp comfort and reduced tightness when using shampoos containing panthenol. However, users consistently state that it does not regrow hair or halt male pattern baldness.

Threads discussing scalp health frequently emphasize that irritation alone does not necessarily cause androgenetic alopecia. Many experienced users stress that controlling DHT with finasteride and stimulating follicles with minoxidil remain the core strategies, while ingredients like panthenol may improve comfort but not follicle miniaturization.

Research Overview and Limitations

The majority of research on vitamin B5 focuses on skin hydration and wound healing rather than hair loss. Many studies involve small sample sizes, short durations ranging from two to eight weeks, and evaluations based on hydration measurements or redness scoring. Few are double-blind, placebo-controlled scalp trials. Direct evidence connecting vitamin B5 to reduced hair shedding is lacking.

Critically, no long-term randomized controlled trials demonstrate that vitamin B5 reduces hair follicle miniaturization or increases hair density in androgenetic alopecia patients.

Final Answer: Can Vitamin B5 Reduce Scalp Dryness and Irritation Linked to Hair Loss?

Possibly. Panthenol is a moisturiser, and reviews of skin studies describe improved hydration and barrier repair, which may ease scalp dryness. It has not been tested on scalp irritation in people with hair loss.

However, no high-quality clinical evidence shows that vitamin B5 treats hair loss itself or reverses androgenetic alopecia. It may improve scalp comfort but does not address hormonal causes such as DHT.

If you are experiencing scalp dryness alongside hair thinning, vitamin B5-containing products may help improve comfort. For hair loss itself, the treatments tested in clinical trials are medicines such as finasteride and minoxidil, which have their own side effects and are best discussed with a doctor. Finasteride's reported side effects are not only sexual: its label also lists depression and suicidal thoughts, breast and semen changes, and sexual and mood symptoms that some men report continuing after stopping; how often that happens is not known (Propecia prescribing information; MHRA, May 2026; see the FAQ "Is finasteride safe?").

References

European Commission. (2023). CosIng database: Panthenol. Retrieved from https://ec.europa.eu/growth/tools-databases/cosing/

National Institutes of Health. (2022). Pantothenic Acid Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/PantothenicAcid-HealthProfessional/

U.S. Food and Drug Administration. (2023). Cosmetics overview. https://www.fda.gov/cosmetics

Ebner, F., Heller, A., Rippke, F., & Tausch, I. (2002). Topical use of dexpanthenol in skin disorders. American Journal of Clinical Dermatology, 3(6), 427–433. https://pubmed.ncbi.nlm.nih.gov/12113650/

Weber, B., & Hylwa, S. (2025). Panthenol allergic contact dermatitis: Sources of exposure, reported cases, and a call for more frequent testing. Dermatitis, 36(4), 343–351. https://pubmed.ncbi.nlm.nih.gov/39714944/

Propecia (finasteride) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f904709-65aa-44ce-b144-b4c8a0416e36

MHRA Drug Safety Update (11 May 2026). Finasteride and dutasteride: updated safety warnings for psychiatric side effects and sexual dysfunction. https://www.gov.uk/drug-safety-update/finasteride-and-dutasteride-updated-safety-warnings-for-psychiatric-side-effects-and-sexual-dysfunction